• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

Possible mechanism of hematopietic stem cells homing to the bone marrow microenvironment

Research Project

Project/Area Number 13671048
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionKYOTO UNIVERSITY (2002)
The University of Tokyo (2001)

Principal Investigator

MAEKAWA Taira  Departments of Transfusion Medicine and Cell Therapy, Professor of Medicine, 医学研究科, 教授 (80229286)

Co-Investigator(Kenkyū-buntansha) TSUJI Kouichiro  Department of Pediatrics, The Institute of Medical Science, University of Tokyo, Associate Professor, 医科学研究所, 助教授 (50179991)
Project Period (FY) 2001 – 2002
Keywordscord blood transplantation / hematopietic stem cell / chemokine / homing
Research Abstract

We found that the stromal cell derived factor-1/pre-B cell growth stimulating factor (SDF1/PBSF) receptor, CXCR4, is expressed on human CD34^+ bone marrow (BM) cells. Stringently FACS-sorted CD34^+CXCR4^+ BM cells completely lack myeloid, erythroid, megakaryocytic, and mixed colony forming potential (myeloid progenitors), but give rise to B and T lymphoid progenitors, whereas CD34^+CXCR4^- BM cells can generate colonies formed by myeloid progenitors and can also develop into these lymphoid progenitors. Therefore, expression of CXCR4 on CD34^+ BM cells can allow lymphoid progenitors to be discriminated from myeloid progenitors. Since CD34^+CXCR4^+ cells are differentiated from CD34^+CXCR4^- cells, multipotential progenitors located in the BM are likely to be negative for CXCR4 expression. CXCR4 seems to be expressed earlier than the interleukin-7 receptor and terminal deoxynucleotidyl transferase during early lymphohemopoiesis. These results suggest that the expression of CXCR4 on CD34^+ BM cells is one of the phenotypic alterations for committed lymphoid progenitors.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Ma, F.A.et al.: "Development of human lymphohematopoietic stem/progenitor cells defined by CD34 and CD"Blood. 97. 3755-3762 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyamoto, S.et al.: "Inhibitory effects of interleukin-3 on early development of human B lymphopoiesis"Brit J Haematology. 114. 690-697 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tomonari, A.et al.: "Severe auto immune thrombocytopenie after allogeneic bone marrow transplantation for a plastic"Int. J. Hematology. 74. 228-232 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kimura, S.et al.: "Nephrotic syndrome with crescent formation and massive IgA deposition and hypothyroidism"Blood. 101. 4219-4221 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kuroda, J.et al.: "The third-generation bisphosphonate Zoldronate synergistically augments the anti-Ph+ leukemia"Blood. (印刷中). (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshimasu, T.et al.: "MxA protein expression in patients with virol infection after allogeneic stem cell transplantation"Bone Marrow Transplantation. (印刷中). (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ma, R., Wada, M., Yoshino, H., Ebihara, Y., Ishii, T., Manabe, A., Tanaka, R., Maekawa. T., Itoh, M., Mugishima, H., Asano, S., Nakahata, T., Tsuji, K.: "Development of human lymphohematopoietic stem/progenitor cells defined by CD34 and CD81 expressions"Blood. 97. 3755-3762 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miyamoto, S., Tsuji, K., Maekawa. T., Asano, S., Nakahata, T.: "Inhibitory effect of interleukin-3 on early development of human B-lymphopoi esis"Brit J Haematol. 114(3). 690-697 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tomonari, A., Tojo, A., Iseki, T., Ooi, J., Nagayama, H., Ogami, K., Maekawa, T., Shirafuji, N., Tani, K., Asano, S.: "Severe autoimmune thrombocytopenia after allogeneic bone marrow transplantation for aplastic anemia"Int J Hematol. 74(2). 228-232 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kimura, S., Horie, A., Hiki, Y., Yamamoto, C., Suzuki, S., Kuroda, J., Kobayashi, Y., Yoshikawa, T., Deguchi, M., Mineo, T., Kato, G., Karasuno, T., Hiraoka, A., Maekawa. T.: "Nephrotic syndrome with crescent formation and massive IgA deposition and hypothyroidism following hematopoietic stem cell transplantation"Blood. 101. 4219-4221 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kuroda, J., Kimura S., Kobayashi, Y., Yoshikawa, T., Urasaki, Y., Ueda, T., Enjo, F., Tokuda, H., Ottmann, O.G., Maekawa, T.: "The third-generation bisphosphonate Zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate"Blood. (in press). (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshimasu, T., Manabe, A., Ebihara, Y., Tanaka, R., Ooi, J., Iseki T., Shirafuji N., Maekawa, T., Asano S., Yoshikawa N., Tsuji K.: "MxA expression in patients with viral infection after allogeneic stem cell transplantation"Bone Marrow Transplant. (in press). (2003)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi